You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
NEW YORK – Rare cell analysis firm RareCyte said on Thursday that is has raised $22 million from new and existing investors.
The financing was led by HealthQuest Capital, with participation from 5AM Ventures and RareCyte founder Ron Seubert.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.
According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.
The US National Institutes of Health has a new initiative to address structural racism in biomedical research.
In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.